Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
JAMA Neurology
|
October 21, 2017
Demystifying Neurosarcoidosis and Informing Prognosis
Jeffrey M Gelfand
JAMA Neurology
|
January 6, 2017
Risk of Multiple Sclerosis After a Clinically Isolated Syndrome: From Magnetic Resonance Imaging to Oligoclonal Bands to Activated T Cells
Jeffrey M Gelfand
Handbook of Clinical Neurology
|
February 11, 2014
Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation
Jeffrey M Gelfand
The American Journal of Psychiatry
|
September 2, 2015
One Brain, Two Specialties, Converging Mechanisms: Neuronal Autoantibodies as a Rare Cause of Postpartum Psychosis
Jeffrey M Gelfand
The Lancet. Neurology
|
July 28, 2018
Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis
Jeffrey M Gelfand
Current Treatment Options in Neurology
|
March 22, 2015
Therapeutic management of severe relapses in multiple sclerosis
Carolyn Bevan, Jeffrey M Gelfand
JAMA Neurology
|
May 19, 2020
Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment
Jeffrey M Gelfand, Jinoos Yazdany
Brain : a Journal of Neurology
|
May 8, 2013
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration
Jeffrey M Gelfand, Ari J Green
Neurology. Clinical Practice
|
May 1, 2023
Autoimmune Encephalitis Consensus Criteria: Lessons Learned From Real-World Practice
Jeffrey M Gelfand, Chu-Yueh Guo
Mededportal : the Journal of Teaching and Learning Resources
|
August 2, 2021
Foundational Telemedicine Workshop for First-Year Medical Students Developed During a Pandemic
Susannah Cornes, Jeffrey M Gelfand, Brook Calton
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
JAMA Neurology
|
October 21, 2017
Demystifying Neurosarcoidosis and Informing Prognosis
Jeffrey M Gelfand
JAMA Neurology
|
January 6, 2017
Risk of Multiple Sclerosis After a Clinically Isolated Syndrome: From Magnetic Resonance Imaging to Oligoclonal Bands to Activated T Cells
Jeffrey M Gelfand
Handbook of Clinical Neurology
|
February 11, 2014
Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation
Jeffrey M Gelfand
The American Journal of Psychiatry
|
September 2, 2015
One Brain, Two Specialties, Converging Mechanisms: Neuronal Autoantibodies as a Rare Cause of Postpartum Psychosis
Jeffrey M Gelfand
The Lancet. Neurology
|
July 28, 2018
Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis
Jeffrey M Gelfand
Current Treatment Options in Neurology
|
March 22, 2015
Therapeutic management of severe relapses in multiple sclerosis
Carolyn Bevan, Jeffrey M Gelfand
JAMA Neurology
|
May 19, 2020
Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment
Jeffrey M Gelfand, Jinoos Yazdany
Brain : a Journal of Neurology
|
May 8, 2013
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration
Jeffrey M Gelfand, Ari J Green
Neurology. Clinical Practice
|
May 1, 2023
Autoimmune Encephalitis Consensus Criteria: Lessons Learned From Real-World Practice
Jeffrey M Gelfand, Chu-Yueh Guo
Mededportal : the Journal of Teaching and Learning Resources
|
August 2, 2021
Foundational Telemedicine Workshop for First-Year Medical Students Developed During a Pandemic
Susannah Cornes, Jeffrey M Gelfand, Brook Calton
Page
of 13